Clinical Trial Update: Efficacy of Moxifloxacin/Prednisolone in Prevention of Post Surgery Inflammation [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a moxifloxacin/prednisolone ophthalmic formulation to prevent postoperative ocular inflammation; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eye Infection
• Ocular Inflammation
• Postoperative Ocular Inflammation

Drugs mentioned

• Moxifloxacin/prednisolone ophthalmic suspension (moxifloxacin/prednisolone)

Snippet

Sponsor: Adapt Produtos Oftalmológicos Ltda. | Conditions: Eye Infection/Inflammation Other | Phase 3 | Status: UNKNOWN